Cassava Sciences Resolves SEC Investigation

3 weeks ago

AUSTIN, Texas, Sept. 26, 2024 ( GLOBE NEWSWIRE ) -- Cassava Sciences, Inc. ( "Cassava" or the "Company" ) ( Nasdaq: SAVA ) , a biotechnology company focused on Alzheimer's disease, today announced that it has reached a settlement with the U.S.

Ticker	Sentiment	Impact
SAVA	Neutral	11 %